Efficacy comparison of trimetazidine with therapeutic alternatives in stable angina pectoris: a network meta-analysis.
about
The role of trimetazidine in cardiovascular disease: beyond an anti-anginal agentDrug efficacy in treating stable angina pectoris: a protocol for network meta-analysis of randomised controlled trialsEffects of trimetazidine in patients with acute myocardial infarction: data from the Korean Acute Myocardial Infarction Registry.Economic evaluation of trimetazidine in the management of chronic stable angina in GreeceTrimetazidine does not alter metabolic substrate oxidation in cardiac mitochondria of target patient population.Trimetazidine and cardioprotection: facts and perspectives.Relative efficacy of antianginal drugs used as add-on therapy in patients with stable angina: A systematic review and meta-analysis.Defining the role of trimetazidine in the treatment of cardiovascular disorders: some insights on its role in heart failure and peripheral artery disease.Trimetazidine in Practice: Review of the Clinical and Experimental Evidence.Pharmacological Agents Targeting Myocardial Metabolism for the Management of Chronic Stable Angina : an Update.Emerging drugs for the treatment of angina pectoris.Modulation of myocardial energetics: An important category of agents in the multimodal treatment of coronary artery disease and heart failure.Expert consensus document: A 'diamond' approach to personalized treatment of angina.Effect of trimetazidine on recurrent angina pectoris and left ventricular structure in elderly multivessel coronary heart disease patients with diabetes mellitus after drug-eluting stent implantation: a single-centre, prospective, randomized, doubleClinical Acceptability Of Trimetazidine Modified-Release 80 mg Once Daily Versus Trimetazidine Modified-Release 35 mg Twice Daily In Stable Angina Pectoris.Anti-Anginal Effectiveness and Tolerability of Trimetazidine Modified Release 80 Mg Once Daily in Stable Angina Patients in Real-World Practice
P2860
Q26741061-B40D2F94-2B80-45E6-8BC6-D1C0312D7CD5Q30487071-C24202F8-7640-4F44-9439-EBF02BC3DAF3Q30663718-FB452CF7-0C08-4C44-81DA-49E5FFA2D3AEQ36146507-464FE618-A2C5-4104-812F-CB557B08A1B7Q36797382-34B37139-CC88-46E4-9853-032926762239Q38203492-827D11E4-AF7D-4216-A0F6-2433A61C61EDQ38207815-D0BF9E7E-7BF8-4474-A2E9-97D39B29782FQ38217985-27968326-E5A3-4A34-AF79-40603DA3A29CQ38371888-7E458A88-506C-46EC-8138-47B5A443519FQ38920729-1BF75951-4ADC-4DC5-984B-567BE1CECD06Q38967994-5A79A03A-5253-4B2C-9F31-97399FBF639AQ39397055-891D08C4-862D-49E3-93B7-F5FDF2CB842DQ48022963-A379FA61-E2D4-4DDC-8209-8FE875276289Q53631221-D5935442-85C5-4CB0-A9BF-EC8C7CCB684FQ55357833-EA5FBE07-FB6B-4203-8A4B-81D535417C36Q58784311-5BD9E7B3-02AA-42E8-8B50-13EEDE5E7E9D
P2860
Efficacy comparison of trimetazidine with therapeutic alternatives in stable angina pectoris: a network meta-analysis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Efficacy comparison of trimeta ...... oris: a network meta-analysis.
@en
Efficacy comparison of trimeta ...... oris: a network meta-analysis.
@nl
type
label
Efficacy comparison of trimeta ...... oris: a network meta-analysis.
@en
Efficacy comparison of trimeta ...... oris: a network meta-analysis.
@nl
prefLabel
Efficacy comparison of trimeta ...... oris: a network meta-analysis.
@en
Efficacy comparison of trimeta ...... oris: a network meta-analysis.
@nl
P2093
P2860
P356
P1433
P1476
Efficacy comparison of trimeta ...... oris: a network meta-analysis.
@en
P2093
Alexander Parkhomenko
Jorge P Ribeiro
Mario Marzilli
Nicolas Danchin
P2860
P356
10.1159/000332369
P407
P577
2011-11-25T00:00:00Z